Viral persistence in colorectal cancer cells infected by Newcastle disease virus
Author:
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Virology
Link
https://link.springer.com/content/pdf/10.1186/1743-422X-11-91.pdf
Reference31 articles.
1. Zamarin D, Palese P: Oncolytic Newcastle disease virus for cancer therapy. Future Microbiol. 2012, 7: 1-21. 10.2217/fmb.11.110.
2. Freeman AI, Zakay-Rones Z, Gomori JM, Linetsky E, Rasooly L, Greenbaum E, Rozenman-Yair S, Panet A, Libson E, Irving CS, Galun E, Siegal T: Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme. Mol Ther. 2006, 13: 221-228. 10.1016/j.ymthe.2005.08.016.
3. Lorence RM, Roberts MS, O’Neil JD, Groene WS, Miller JA, Mueller SN, Bamat MK: Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus. Curr Cancer Drug Targets. 2007, 7: 157-167. 10.2174/156800907780058853.
4. Russell SJ, Peng KW, Bell JC: Oncolytic virotherapy. Nat Biotechnol. 2012, 30: 1-13.
5. Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P: A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 2007, 3 (10): e141-10.1371/journal.ppat.0030141.
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Viral therapy for targeted drug delivery to cancers: Recent advances, clinical and regulatory perspectives;Journal of Drug Delivery Science and Technology;2024-02
2. Delivery of a novel membrane-anchored Fc chimera enhances NK cell-mediated killing of tumor cells and persistently virus-infected cells;PLOS ONE;2023-05-05
3. Analysis of PPI networks of transcriptomic expression identifies hub genes associated with Newcastle disease virus persistent infection in bladder cancer;Scientific Reports;2023-05-05
4. Metabolic Reprogramming in Colon Cancer Cells Persistently Infected with Newcastle Disease Virus;Cancers;2023-01-28
5. Oncolytic viruses in immunotherapy;Cancer Immunology and Immunotherapy;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3